FRCPath Haem Part 1 EMQs-Haemostasis 517

Question: Match each anticoagulant with its approximate plasma half-life.
Option | Anticoagulant half-life |
A | 1–2 hours |
B | 4–5 hours |
C | 12 hours |
D | 17–21 hours |
E | 25 hours |
F | 36–48 hours |
G | 7–10 hours |
Clinical scenarios
1. A 72-year-old man develops significant gastrointestinal bleeding following initiation of intravenous anticoagulation for an acute pulmonary embolism. He is receiving an anticoagulant that can be reversed using protamine sulphate.
2. A 68-year-old woman with previous pulmonary embolism presents with a spontaneous retroperitoneal haematoma. She is receiving therapeutic subcutaneous anticoagulation. Protamine provides partial reversal.
3. A 75-year-old man with previous venous thromboembolism develops significant bleeding whilst receiving a synthetic pentasaccharide anticoagulant. The drug is predominantly renally excreted and has no specific reversal agent.
4. A 70-year-old woman with heparin-induced thrombocytopenia develops major gastrointestinal bleeding whilst receiving an alternative parenteral anticoagulant. The drug has a relatively prolonged half-life and is predominantly renally cleared.
5. An 80-year-old man presents with an intracranial haemorrhage whilst taking an oral direct thrombin inhibitor for atrial fibrillation. Idarucizumab is administered for emergency reversal.

Comments